Ranked #36 of 43 · scores higher than 17% of peers · safety percentile 20
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)
12 peers with a safety percentile of 20–29, including GSK · Click a bar to see the companies
Why “Higher relative risk”?
The measures below combine into a safety percentile of 20 among Healthcare companies. It is relative: 67 or more is lower relative risk, 33–66 moderate, below 33 higher.
Mainly because of its current ratio and debt / equity, which are weaker than most Healthcare peers.
▼fewer short-term assets to cover bills due within a year: weaker than 95% of peers. Current ratio: 0.82× vs peer median 2.59×
▼more borrowing relative to shareholders' equity: weaker than 86% of peers. Debt / equity: 1.08× vs peer median 0.22×
▲a share price that has swung less with the market: stronger than 68% of peers. Beta: 0.29 vs peer median 0.63
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
Metric by metric
Position: dot = GSK, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
